CRX and pineoblastoma: CRX (Cone-rod homeobox protein) has been proposed as a sensitive and specific clinical marker and potential therapeutic target in retinoblastoma and pineoblastoma [43], and is essential for growth of tumor cells with photoreceptor differentiation [44].